Clinical Trial: A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Overweight
Study Type: INTERVENTIONAL
Official Title: A Double-blind, Randomized, Placebo-controlled, Multiple-dose, Parallel Group With Nested Crossover Design Trial With Moxifloxacin as Positive Control to Evaluate the Effects of Multiple Subcutaneous
Brief Summary:
This study is open to adults between 18 and 55 years of age with overweight or obesity.The purpose of this study is to find out whether a medicine called survodutide (BI 456906) has an effect on cardiac safety.When a new medicine is developed, it is important to check whether it affects the heart.Moxifloxacin is a medicine that is known to change the heart rhythm.In this study, moxifloxacin is used as a so-called positive control.Participants are put into 3 groups by chance.There is a different treatment schedule…
Read more